A 5-year retrospective study of treatment outcome in acute myeloid leukemia (AML) patients

Mai Khaled Abdel Aziz Bishr;

Abstract


This is a retrospective observational study aiming at evaluation of response, and relapse rates as well as survival outcome of acute myeloid leukemia (AML) patients treated at our institute.
Patients & Methods:
The study included 117 AML patients presented to Kasr Al Ainy Center of Radiation Oncology and Nuclear Medicine (NEMROCK) during the period from January 2010 to December 2014.
We reviewed patients’ files for clinical and pathological characteristics as well as details of treatment and response. Patients diagnosed as acute promyelocytic leukemia (APL) were identified and analyzed separately.
Results:
Ninety non-APL patients were included in the study, having mean age of 37.8 years and slight female predominance (male: female ratio 1:1.3). The most common French-American-British (FAB) subtypes were M2 and M5 representing 22% and 21% of patients, respectively.
Complete remission (CR) rate was 65%, 13.8% of patients


Other data

Title A 5-year retrospective study of treatment outcome in acute myeloid leukemia (AML) patients
Authors Mai Khaled Abdel Aziz Bishr
Issue Date 2016

Attached Files

File SizeFormat
v1355.pdf321.51 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.